Hallett David bought RXRX
February 6, 2026 · Form 4 insider transaction
Hallett David bought 502,064 shares of Recursion Pharmaceuticals, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
502,064
Price
$0.00
Total value
N/A
InsiderHallett David
Role—
SecurityClass A Common Stock
Transaction codeA: Grant or award
Transaction dateFebruary 6, 2026
Filing dateFebruary 10, 2026
Shares owned after1,096,205
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
This RSU vests as to one one-sixteenth (1/16th) of the units subject the RSU on May 15, 2026 and every three months thereafter.